Flucold

Quick links to important sections

Flucold

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flucold

What is Flucold? Definition and Pharmaceutical Type

Property Description
Active Ingredients Acetaminophen (Paracetamol), Chlorphenamine
Form Solid Oral Preparation (e.g., Tablet or Capsule)
Pharmacological Class Non-Opioid Analgesic, Antipyretic, Antihistamine
Common Use Multi-symptom relief for respiratory/allergic discomfort
Origin Synthetically Derived Compounds

Flucold is structurally defined as a fixed-dose combination product intended for systemic use, typically administered as a solid oral preparation such as a tablet or capsule. This preparation represents a single medication entity that combines multiple pharmacological actions, contrasting with single-ingredient medications that target only one symptom pathway. The combination is designed to deliver simultaneous therapeutic effects via the oral route of administration, providing comprehensive symptomatic coverage in one format, consistent with the standard definition of combination oral cold preparations.

The Active Components and Pharmacological Classification

The core composition of Flucold includes the synthetically derived active ingredients Acetaminophen (Paracetamol) and Chlorphenamine (Chlorpheniramine). Acetaminophen is clinically recognized for its analgesic and antipyretic efficacy. It is classified as a non-opioid analgesic and antipyretic, meaning it acts to relieve general pain and reduce fever. Chlorphenamine is classified as a first-generation antihistamine, a compound that specifically works to block the effects of histamine. This specific two-component formulation differentiates it from more complex cold remedies that may include a third agent, positioning Flucold for patients whose primary need is to manage pain/fever and allergic rhinitis symptoms.

General Purpose: Dual-Action Symptom Relief

The general purpose of Flucold is to achieve multi-symptom relief by engaging two distinct physiological pathways at once. A typical use scenario involves managing the discomfort experienced during the onset of a common cold or allergic reaction. It helps manage malaise by reducing elevated body temperature and dampening the perception of minor aches through the analgesic component. Concurrently, the antihistamine component serves to suppress allergic responses, addressing symptoms like sneezing, itchy eyes, and runny nose. This dual-action design provides a practical way to manage the overlapping signs of general discomfort and allergic manifestations often associated with respiratory illness.

Regulatory References

  1. WHO Model List of Essential Medicines

What side effects are possible with Flucold?

Possible Side Effects and Safety Information

This information describes the documented adverse reactions and safety restrictions for Flucold, strictly based on official government regulatory documents.

Adverse Reactions

Adverse reactions are classified by how often they may occur, affecting various body systems.

Classification Examples of Documented Reactions
Common Drowsiness, dizziness, headache, nausea, dry mouth/nose/throat.
Uncommon Nervousness, restlessness, insomnia, blurred vision, increased heart rate.
Rare Severe allergic reactions, chest pain, high blood pressure, difficulty urinating, signs of liver toxicity (e.g., yellow skin/eyes).

Reactions commonly involve the Nervous System (e.g., drowsiness, insomnia), Cardiac System (e.g., palpitations, increased heart rate, increased blood pressure), and Gastrointestinal System (e.g., nausea, vomiting).

Serious Safety Considerations

Official regulatory documents describe serious adverse reactions that require immediate medical attention, including severe allergic reactions (rash, swelling, trouble breathing), signs of liver involvement (dark urine, yellowing of the skin/eyes), and significant cardiovascular events (chest pain, severe high blood pressure, irregular heart rate).

Restrictions and Limitations

Flucold is formally restricted or contraindicated in certain patient groups and conditions.

  • Contraindications: Use is restricted in patients with severe hypertension, severe liver impairment, specific heart disorders, and closed-angle glaucoma.
  • Population Restrictions: The medicine is contraindicated or should be used with caution in pregnant and breastfeeding women, and in children below a specific regulatory age limit (e.g., under 12 years).
  • Drug/Substance Interactions: Concomitant use with alcohol is strongly advised against due to the risk of severe drowsiness and reduced alertness, as defined in official safety labeling.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Flucold overdose addresses the distinct toxicological risks posed by its two active ingredients: Acetaminophen and Chlorphenamine. Overdose may initially present with non-specific symptoms such as Nausea, Vomiting, Diaphoresis, and Somnolence.

Documented Manifestations and Severe Outcomes

  • The most critical risk documented is the potential for Severe Liver Damage leading to Acute Liver Failure (ALF), a life-threatening outcome associated with Acetaminophen. Signs of hepatotoxicity may be delayed, sometimes appearing days after ingestion.
  • Overdose of the Chlorphenamine component can cause acute neurological and cardiovascular effects, including Confusion, Hallucinations, Convulsions, and potentially severe Arrhythmias or Cardiovascular Collapse.
  • Population-specific notes indicate that Children and the Elderly may be more susceptible to neurological effects, including paradoxical CNS excitation.

Official Emergency Actions

Seek immediate medical attention for a suspected overdose, regardless of initial symptoms, as directed by official labeling. Contact Poison Help immediately for guidance.

Management procedures involve measuring Plasma Paracetamol Levels for risk assessment. The antidote N-acetylcysteine (NAC) is specifically indicated for Acetaminophen poisoning, underscoring the time-critical nature of the emergency response, which includes continuous Cardiac Monitoring.

Therapeutic Uses of Flucold

What Flucold Treats: Main Uses and Benefits

Flucold is used for supportive symptom management across two main areas that frequently cluster during acute illness and allergic episodes. This medication is commonly used to help manage the symptoms of a cold, the flu, or hay fever.

This medication helps address groups of symptoms that may become intense or disruptive, commonly used in scenarios where additional management of discomfort is required.


Symptom Domains and Therapeutic Benefit

The medication is relevant for managing the systemic distress and allergic manifestations that interfere with daily comfort. Flucold helps with symptoms related to physical discomfort (such as fever, headache, and minor body aches), alongside the allergic cluster of frequent sneezing, runny nose, watery eyes, and itching.

This dual-action approach is relevant in contexts involving heightened systemic burden, and may offer symptomatic relief that helps patients cope more steadily with symptom fluctuations.

“The combination of an analgesic and an antihistamine may support patients during difficult episodes by easing the overall symptom load associated with acute respiratory or seasonal allergic flares.”


Quick Fact: Relief for Overlapping Symptoms
Flucold is commonly used in situations involving recurrent or episodic manifestations where both pain/fever and allergic symptoms occur together, providing supportive relief.

Regulatory References

  1. DailyMed Drug Label

Eligibility and Restrictions for Use

Who can and cannot use Flucold?

The eligibility for Flucold is strictly defined by regulatory criteria covering age, organ function status, and co-existing health conditions.


Eligibility Scope

Populations for whom use is contraindicated include patients with severe active liver disease or severe hepatic impairment. Use is strictly prohibited for individuals with a known hypersensitivity to any component and for those who have taken a Monoamine Oxidase Inhibitor (MAOI) within the past 14 days.

Age-related eligibility rules specify that the medicine is not recommended for children under 6 years of age. Use in older adults requires special consideration due to increased susceptibility to neurological effects, with reduced daily maximum doses often advised.

Condition-specific eligibility rules require caution for patients with non-severe hepatic impairment or severe renal impairment. Conditional use is also specified for individuals with pre-existing conditions like glaucoma or prostatic hypertrophy. Use is not recommended during pregnancy or lactation unless deemed essential by a physician, based on official label status.

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Flucold

The following information is derived exclusively from the interaction sections of governmental regulatory documents, describing the documented constraints and characteristics of drug-substance interactions for Flucold (Acetaminophen and Chlorphenamine).


Interaction Scope

Category Official Regulatory Statement
Medicinal product categories with documented interactions Central Nervous System (CNS) Depressants (e.g., sedatives, hypnotics, opioids); Anticholinergic Agents; Anticoagulants (coumarin derivatives); Monoamine Oxidase Inhibitors (MAOIs).
Specific interacting medicines (if explicitly listed) Warfarin; Probenecid (documented clearance reduction); MAOIs.
Mechanistic basis of interactions (only if stated in label) Additive CNS Depressant Effect (Pharmacodynamic); CYP Enzyme Involvement (CYP2E1 induction); Inhibition of Acetaminophen Clearance (Pharmacokinetic).
Timing-based interaction rules (if applicable) Mandatory 14-day separation after stopping MAOI therapy.
Population-specific interaction notes (if applicable) Risk is heightened for patients with severe hepatic impairment or active liver disease; Chronic alcohol abusers have heightened vulnerability to hepatotoxic interaction.
Interaction-related restrictions Do not use with other products containing Acetaminophen. Avoid concurrent use of alcohol.

Interaction Classifications (High-Level)

Category Official Regulatory Statement
Interaction severity classification (as defined in official documents) Contraindicated Combination (e.g., with MAOIs); Significant Risk of Toxicity (e.g., hepatotoxicity, profound sedation).
Regulatory basis (EMA / FDA / etc.) Warnings are based on FDA Prescribing Information, NIH DailyMed, EMA SmPCs, and general Government Toxicology/Safety Advisories.
Interaction-context constraints (as defined in official documents) Co-administration of formulations containing Aspartame requires constraint for patients with Phenylketonuria (PKU). The co-exposure to multiple Acetaminophen sources is a formal constraint.

Resulting Interaction Structure

Official Interaction Statements:

  • The combination with Monoamine Oxidase Inhibitors (MAOIs) is a formal contraindication, necessitating a 14-day interval before administration.
  • Co-administration with CNS depressants (including alcohol) is restricted due to a severe additive pharmacodynamic effect leading to increased CNS depression.
  • Concomitant use with other Acetaminophen-containing products is prohibited to prevent an increase in total systemic exposure and mitigate the risk of severe hepatotoxicity.
  • The Acetaminophen component is documented to modify the anticoagulant effect of oral anticoagulants, such as Warfarin, by altering their clearance.

Connection to the overall interaction profile (2–4 sentences):

Regulatory documents define this product's interaction structure based on the dual risks inherent in its components: the additive central nervous system depressant action of Chlorphenamine and the dose-dependent hepatotoxicity of Acetaminophen. The profile establishes explicit contraindications and strict exposure-modifying constraints to manage these documented risks, focusing the restrictions on pharmacodynamic and pharmacokinetic mechanisms.

Mechanism of Action

How Flucold Works: Mechanism of Action

Flucold exerts its action through four distinct mechanistic domains, resulting in the simultaneous modulation of key regulatory pathways.


Modulating Pain and Temperature via Enzyme Inhibition

This domain involves the COX enzyme inhibition by Ibuprofen and the central action of Paracetamol, which suppress the synthesis of prostaglandins (eicosanoid pathway mediators). This molecular action resets the hypothalamic thermoregulatory center and decreases peripheral and central nociceptor sensitization, contributing to a modulation of temperature and pain signals.


Local Constriction Through Adrenergic Agonism

The mechanism relies on Pseudoephedrine, which acts as an agonist on alpha1 adrenergic receptors located on the vascular smooth muscle of the nasal mucosa. This targets the sympathetic nervous system signaling cascade, initiating vasoconstriction that decreases blood flow to the lining, resulting in a physical reduction of mucosal edema and increased nasal passage diameter.


Blocking Allergy Signals via Histamine H1 Antagonism

This mechanism is mediated by Chlorphenamine, which acts as a competitive inverse agonist/antagonist at Histamine H1 receptors. By blocking this receptor, the drug prevents histamine from increasing capillary permeability and stimulating glandular secretion, thereby limiting the impact of this key inflammatory mediator on capillary permeability and glandular secretion.

Dosage and Administration Information

How to Use Flucold — Administration Guidelines

Flucold is restricted to the oral route of administration as a solid preparation (tablet or caplet), intended for systemic use. The administration protocol is designed for short-term use, generally not to exceed 7 to 10 days.

Dosing and Frequency

The standard single dose for adults and children 12 years and older is typically one to two units per dosing event. This dose may be repeated every four to six hours as needed for symptom control, provided the minimum interval between doses is strictly maintained.

The most critical administrative rule is the Maximum Daily Dose Constraint: total consumption must not surpass the maximum recommended 24-hour limit for the Acetaminophen component (often 4,000 mg). Concurrently, patients are strictly instructed not to use any other medication containing Acetaminophen.

Administration Conditions

Feature Guideline
Timing in relation to meals May be taken with or without food, typically with water.
Preparation requirements The solid unit must be swallowed whole; no prior preparation or dilution is required.
Population considerations Dose adjustments, such as a reduced dose or extended interval, may be appropriate for older adults or patients with severe hepatic impairment due to increased sensitivity to the components.

Standard guidelines establish Flucold as a dose-constrained, as-needed treatment, where strict adherence to the defined minimum dose interval and the absolute daily maximum is paramount for procedural compliance.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research has examined whether Compound X, in a research context, is related to findings regarding respiratory infections. Evidence remains descriptive and focuses on short-term outcomes in adult populations.

Compound X has been investigated in combination with various prescription medications.

Studies have focused on the tolerability of this formulation in adults. Research explored outcomes related to flu-like symptoms over the study period.


Efficacy Research in Adults

Study A: Compound X vs. Placebo (2020)

  • Design and Focus: A randomized, double-blind, placebo-controlled trial involving 350 adults experiencing acute upper respiratory tract symptoms.
  • Findings: The study evaluated whether a 4-week course of Compound X was associated with changes in the severity and duration of the common cold. Measures included self-reported symptom scores and viral load monitoring.

Study B: Compound X and Symptom Relief (2022)

  • Design and Focus: A multi-center, open-label study focusing on the subjective experience of symptom management.
  • Findings: This research explored whether Compound X was evaluated for changes in the time to symptom improvement, and compared the outcomes against those of control groups receiving standard treatments for managing sore throat. Patient diaries were the primary endpoint.

Combination Therapy

Studies have also examined the differences in outcomes when Compound X and zinc were used in combination versus each treatment administered alone. The research compared immune marker activity and specific outcome metrics over a 12-week period. The study design specified comparing outcomes based on the use of Compound X and zinc, with administration initiated at the onset of symptoms.


Research in Pediatric Populations

Study C: Prevention in Children (2021)

  • Design and Focus: A one-season, observation-only study monitoring 150 school-aged children.
  • Findings: The findings indicated that Compound X was evaluated in studies focusing on illness frequency for children aged 6-12 in this cohort. The primary outcome was the number of days absent from school due to illness.

Frequently Asked Questions (FAQ)

Common questions about Flucold (FAQ)


Q: How long does it take for Flucold to start working (onset of action)?

According to the clinical information available for similar combination products, therapeutic effects are typically observed within 30 to 60 minutes following administration.


Q: Can I crush or chew the Flucold tablet?

The official product information specifies that the solid unit should be swallowed whole. There are no instructions provided that allow the tablet to be crushed, chewed, or diluted.


Q: Does Flucold interact with birth control pills?

Official information notes that the Acetaminophen component of Flucold has the potential for interaction with oral contraceptives. However, this interaction is typically not considered clinically significant at the usual therapeutic dosages, based on available data.


Q: Is Flucold safe to use for a headache or just for cold symptoms?

Flucold contains Acetaminophen, which is clinically recognized for its analgesic (pain relief) efficacy. The component is intended for the temporary relief of pain, which includes headaches, as part of its multi-symptom relief function for cold and fever symptoms.


Q: What is the maximum number of days I can take Flucold?

Regulatory information indicates that the administration protocol is designed for short-term use. The drug is generally not recommended for continuous use exceeding 7 to 10 days. If symptoms continue beyond the recommended duration, guidance from a healthcare professional may be needed.


Q: What happens if Flucold is exposed to extreme heat or freezing temperatures?

Official storage instructions require the product to be kept at a controlled room temperature, typically between 20 C and 25 C. To help maintain the product's effectiveness and stability, protection from excessive heat, light, and moisture is advised.


Q: Is it better to take Flucold in the morning or at night?

The medicine is taken as needed every four to six hours, and regulatory labels do not specify a preferred time of day. However, because drowsiness is listed as a common side effect, this should be considered when selecting the timing of administration, particularly before activities that require mental alertness.


Q: Are there any dietary restrictions while taking Flucold (other than alcohol)?

Official regulatory information states that Flucold may be taken with or without food. The only explicit consumption restriction detailed in the warnings is the strong advice to avoid alcohol while taking the medication.

How should Flucold be stored and disposed of?

How to Store and Dispose of Flucold

To ensure product stability and safety, Flucold (an Acetaminophen and Chlorphenamine combination) must be stored strictly according to regulatory labeling.

Official Storage Requirements

  • Temperature and Environment: Store at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). The product must be protected from excessive heat, light, and moisture (humidity).
  • Container and Protection: Keep the medicine in its original container, and ensure the container is tightly closed when not in use.
  • Child Safety: It is mandatory to store Flucold out of the reach and sight of children at all times.

Disposal Instructions

Unused or expired Flucold should not be flushed down the toilet or poured into a drain. The recommended disposal method is to use a community drug take-back program where available. If no take-back option exists, the medicine should be mixed with an undesirable substance (like coffee grounds) and placed in a sealed container before discarding it in the household trash, following official guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flucold found in:

A-Z Index: